Internal Medicine, Hematology & Oncology · Denison, TX
NPI
1659319028
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
5125 Texoma Medical Center Dr Ste 100
Denison, TX, 75020
Phone (903) 868-4700
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.1M
204,952 services
Medicare patients, 2024
972
Average age 75
Drug cost, 2024
$5.0M
2,654 prescriptions
Company payments, 2025
$8,119
From 36 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amir A Faridi was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 33,150 times for 49 patients. In total Amir A Faridi billed 204,952 services in 181 codes, and Medicare paid $3.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-21.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 33,150 | 49 | $0.26 | $8,619 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 18,100 | 33 | $44.77 | $810K |
| J1756 Injection, iron sucrose, 1 mg | Office | 13,500 | 34 | $0.18 | $2,388 |
| J9299 Injection, nivolumab, 1 mg | Office | 13,260 | 18 | $24.52 | $325K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 12,600 | 18 | $0.05 | $681 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 11,700 | 46 | $0.11 | $1,289 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 6,120 | 17 | $39.50 | $242K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 6,022 | 69 | $0.10 | $595 |
| J9267 Injection, paclitaxel, 1 mg | Office | 5,960 | 19 | $0.08 | $453 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 5,790 | 17 | $2.27 | $13K |
| J0897 Injection, denosumab, 1 mg | Office | 4,440 | 33 | $20.71 | $92K |
| J9171 Injection, docetaxel, 1 mg | Office | 3,345 | 18 | $0.69 | $2,311 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,585 | 105 | $0.09 | $230 |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2,170 | 14 | $36.89 | $80K |
| 85025 Blood Count | Office | 1,909 | 534 | $7.57 | $14K |
By year: 2022 $2.6M for 217,914 services; 2023 $2.7M for 181,447 services; 2024 $3.1M for 204,952 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,909 | 534 | $7.57 | $14K |
| 36415 Venipuncture Blood Collection | 1,897 | 523 | $8.61 | $16K |
| 80053 Clinical Chemistry | 1,707 | 534 | $10.32 | $18K |
| 82728 Clinical Chemistry | 340 | 156 | $13.13 | $4,465 |
| 83540 Clinical Chemistry | 323 | 156 | $6.23 | $2,011 |
| 83550 Clinical Chemistry | 323 | 156 | $8.42 | $2,719 |
| 83615 Clinical Chemistry | 223 | 161 | $5.87 | $1,309 |
| 85055 Blood Count | 127 | 52 | $35.03 | $4,449 |
| 85007 Blood Count | 118 | 47 | $3.69 | $435 |
| 85027 Blood Count | 117 | 47 | $6.28 | $735 |
Medicare prescription drug claims, 2024
In 2024, the drug Amir A Faridi prescribed most often to Medicare patients was Anastrozole, with 214 prescriptions and refills. In total Amir A Faridi wrote 2,654 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 214 | 394 | 46 | $2,135 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 199 | 200 | 56 | $5,399 |
| Prochlorperazine Maleate Generic | 130 | 130 | 77 | $1,311 |
| Dexamethasone Generic | 116 | 125 | 43 | $1,357 |
| Prednisone Generic | 111 | 111 | 29 | $440 |
| Revlimid Lenalidomide | 111 | 111 | 13 | $1.6M |
| Hydroxyurea Generic | 109 | 175 | 17 | $2,817 |
| Acyclovir Generic | 107 | 126 | 21 | $1,125 |
| Gabapentin Generic | 80 | 100 | 24 | $1,022 |
| Eliquis Apixaban | 58 | 78 | 14 | $45K |
| Levothyroxine Sodium Generic | 58 | 78 | 20 | $202 |
| Potassium Chloride Generic | 57 | 78 | 25 | $642 |
| Alprazolam Generic | 52 | 52 | 14 | $177 |
| Ondansetron Hcl Generic | 51 | 51 | 28 | $1,296 |
| Morphine Sulfate Er Morphine Sulfate | 44 | 44 | 14 | $1,177 |
Brand drugs: 525 claims; generic drugs: 2,129 claims; opioid claims: 362.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amir A Faridi $8,119 ($8,119 in general payments such as food, travel and fees) from 36 companies. The largest payer was Sun Pharmaceutical Industries Inc. with $6,348.
| Company | Payments | Amount |
|---|---|---|
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 5 | $6,348 |
| Janssen Biotech, Inc. JNJ | 7 | $287 |
| Incyte Corporation INCY | 4 | $150 |
| Pfizer Inc. PFE | 7 | $138 |
| Daiichi Sankyo Inc. 4568.T | 1 | $99 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $76.53 |
| Aveo Pharmaceuticals, Inc. | 3 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $72.84 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $70.56 |
| Genzyme Corporation SNY | 2 | $62.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.